Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
- PMID: 33658689
- DOI: 10.1038/s41586-020-03132-4
Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
Comment on
-
Hippo signalling maintains ER expression and ER+ breast cancer growth.Nature. 2021 Mar;591(7848):E1-E10. doi: 10.1038/s41586-020-03131-5. Epub 2021 Mar 3. Nature. 2021. PMID: 33658690 Free PMC article. No abstract available.
References
-
- Ma, S. et al. Hippo signalling maintains ER expression and ER+ breast cancer growth. Nature, https://doi.org/10.1038/s41586-020-03131-5 (2021).
-
- Britschgi, A. et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature 541, 541–545 (2017). - DOI
-
- Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by LATS and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 24, 72–85 (2010). - DOI
-
- Totaro, A., Panciera, T. & Piccolo, S. YAP/TAZ upstream signals and downstream responses. Nat. Cell Biol. 20, 888–899 (2018). - DOI
-
- Rossi, A. et al. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature 524, 230–233 (2015). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical